MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-20-0014772
Zenara Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹85.73 Cr
▲ 3% YoY
Net profit · FY 2025
₹11.27 Cr
Net margin 13.1%
EBITDA · FY 2025
₹18.39 Cr
EBITDA margin 21.5%
Authorised capital
₹50 Cr
Registered with MCA
Paid-up capital
₹48.24 Cr
Issued & subscribed
Open charges
₹62.04 Lakh
Satisfied ₹18.89 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
205
Provident fund records
About Zenara Pharma Private Limited
Data last updated:
Zenara Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Biophore India Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 March 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC042894. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹48.24 Cr. It was formerly known as Danmed Pharmaceuticals Private Limited. It is led by directors Manikreddy Pullagurla and Jagadeesh Babu Rangisetty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 83/B 84 87 – 96 Phase III Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹85.73 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹11.27 Cr (net margin 13.1%) and EBITDA of ₹18.39 Cr (EBITDA margin 21.5%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 34% over five years.
The company has about 205 employees on its provident fund (EPFO) records.
The company is associated with 3 brands: Zenara Pharma, Zenara and Biophore. As per MCA filings, the company has open charges of ₹62.04 Lakh and satisfied charges of ₹18.89 Cr on record. The company has 1 deal on record (1 acquisition); the latest was in November 2010. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is BDH Industries Limited with revenue of ₹87.41 Cr.
Zenara Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0014772). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biophore.com.
Company details
CIN U24239TG2004PTC042894
Registration Number 042894
Incorporation Date 18 March 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Parent Company Biophore India Pharmaceuticals Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0014772
CIN history
Zenara Pharma has one previous CIN (Corporate Identification Number): U24239AP2004PTC042894. The current CIN is U24239TG2004PTC042894, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC042894 | Current |
| U24239AP2004PTC042894 | Previous |
Recognitions & Rankings of Zenara Pharma
Contact details
Zenara Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is biophore.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 83/B 84 87 – 96 Phase III Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zenara Pharma Private Limited, buy the company report.
Comprehensive company report
Zenara Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Zenara Pharma operates multiple associated brands including Zenara Pharma, Zenara, and Biophore. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures affordable pharmaceutical products with global approvals. | zenarapharma.com | |
| Specialty contract development and manufacturing services are offered for pharmaceuticals. | zenara.com | |
| Niche generic pharmaceuticals are developed and manufactured for industry needs. | biophore.com |
Business activity
The main business activity of Zenara Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zenara Pharma Private Limited, buy the company report.
Financials of Zenara Pharma Private Limited
FY 2024 filings availableZenara Pharma Private Limited reported revenue of ₹85.73 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹85.73 Cr ▲ 3%
Net profit · FY 2025
₹11.27 Cr margin 13.1%
EBITDA · FY 2025
₹18.39 Cr margin 21.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 32%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 49%
3 years · compounded
▲ 55%
5 years · compounded
▲ 39%
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 3% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.39 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.27 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.5% | ||||
| Net Profit Margin | 13.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zenara Pharma Private Limited, buy the company report.
Board of directors of Zenara Pharma Private Limited
Zenara Pharma has 2 current directors and 26 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manikreddy Pullagurla Also directs: Leiutis Pharmaceuticals LLP, Ewings Ventures LLP, Biolyx Lifesciences Private Limited and 5 more | Director | 21 Jan 2017 | 9 Years 9 Months | Current |
| Jagadeesh Babu Rangisetty Also directs: Leiutis Pharmaceuticals LLP, Ewings Ventures LLP, Envozyme Feeds Private Limited and 5 more | Director | 21 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Zenara Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BDH Industries Limited | ₹87.41 Cr (FY 2024) | 16.0% | Mumbai, Maharashtra, India | |||
| Vidacare Medica Private Limited | ₹87.17 Cr (FY 2025) | -13.0% | Mumbai, Maharashtra, India | |||
| Health Biotech Limited | ₹86.89 Cr (FY 2025) | -22.0% | Chandigarh, India | |||
| Cyano Pharma Private Limited | ₹85.89 Cr (FY 2024) | 38.0% | Mumbai, Maharashtra, India | |||
| Zenara Pharma Private Limitedthis company | ₹85.73 Cr (FY 2025) | ₹11.27 Cr | 13.1% | 3.0% | 205 | Hyderabad, Telangana, India |
| D.D. Pharmaceuticals Pvt. Ltd | ₹85.6 Cr (FY 2024) | 20.0% | Sitapura, Tonk Road, Jaipur., Rajasthan, India | |||
| Sidmak Laboratories (India) Private Limited | ₹85.07 Cr (FY 2025) | -6.0% | Valsad, Gujarat, India | |||
| Nava Healthcare Private Limited | ₹84.21 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Inchem Laboratories Private Limited | ₹84.08 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Zenara Pharma Private Limited, buy the company report.
Auditor
Zenara Pharma Private Limited is audited by VSPN AND CO CHARTEREDACCOUNTANTS for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VSPN AND CO CHARTEREDACCOUNTANTS | FY 2023 | 0008178S |
Shareholding
The shareholding of Zenara Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zenara Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹62.04 Lakh
Satisfied charges
₹18.89 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Aug 2025 | 101158509 | Hdfc Bank Limited | ₹62.04 Lakh | Open | |
| 31 Aug 2021 | 100483421 | Others | ₹5.74 Cr | Satisfied | |
| 28 Dec 2017 | 100146903 | Others | ₹2.85 Cr | Satisfied | |
| 24 Jun 2005 | 90127050 | The South Indian Bank Limited | ₹10.3 Cr | Satisfied |
To see the full charge records of Zenara Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Zenara Pharma Private Limited has 1 deal on record (1 acquisition); the latest was in November 2010.
Total deals
1
Acquisition
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2010 | Acquisition | ₹88.86 Cr | Buyer: Cambrex Corp. |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Zenara Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zenara Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Zenara Pharma Private Limited has a workforce of 205 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
205
Active EPFO establishments
1
Employee growth
15.17%
GST
Zenara Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
Total GSTINs
2
Cancelled / inactive
2
To see the full GST registrations and return filing status of Zenara Pharma Private Limited, buy the company report.
Recent activity
Zenara Pharma Private Limited has 24 board changes on record since 2007: 2 appointments and 22 cessations. The latest: Abhinay Yenumula ceased to be Company Secretary on 31 Jan 2018.
Charges
A charge registered on 28 Dec 2017 via Charge ID 100146903 with Others was fully satisfied on 13 Nov 2025.
AGM
Zenara Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.62 Cr with Charge ID 101158509 was registered on 01 Aug 2025.
Charges
A charge registered on 31 Aug 2021 via Charge ID 100483421 with Others was fully satisfied on 15 Apr 2024.
Filing
Zenara Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others of Rs. 2.85 Cr registered on 28 Dec 2017 with Charge ID 100146903 was modified on 07 Nov 2023.
Charges
A charge with Others amounted to Rs. 5.74 Cr with Charge ID 100483421 was registered on 31 Aug 2021.
Ceased
Abhinay Yenumula ceased to be Company Secretary.
Charges
A charge with Others amounted to Rs. 2.85 Cr with Charge ID 100146903 was registered on 28 Dec 2017.
Ceased
Jagadeesh Babu Rangisetty ceased to be Additional Director.
Ceased
Manikreddy Pullagurla ceased to be Additional Director.
Ceased
Gregory Paul Sargen ceased to be Director.
24 earlier events are in the company report.
News
Frequently asked questions
Zenara Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 March 2004 (22+ years old) and is registered under CIN U24239TG2004PTC042894.
Zenara Pharma has 2 current directors:
- Manikreddy Pullagurla - Director
- Jagadeesh Babu Rangisetty - Director
The latest financial statements of Zenara Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Zenara Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Zenara Pharma is U24239TG2004PTC042894. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zenara Pharma was incorporated on 18 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Zenara Pharma has 1 deal on record (1 acquisition); the latest was in November 2010.
The peers of Zenara Pharma by revenue are BDH Industries Limited, Vidacare Medica Private Limited, Health Biotech Limited, Cyano Pharma Private Limited, D.D. Pharmaceuticals Pvt. Ltd and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Abhinay Yenumula ceased to be Company Secretary on 31 Jan 2018. Jagadeesh Babu Rangisetty ceased to be Additional Director on 29 Sep 2017. Manikreddy Pullagurla ceased to be Additional Director on 29 Sep 2017. Zenara Pharma has 24 board changes on record in total.
Yes, Zenara Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0014772).
Zenara Pharma can be reached through the website biophore.com. Its registered office is in Hyderabad, Telangana, India.